Sholl LM - Search Results

1

Myc protein expression correlates with MYC amplification in small-cell lung carcinoma.

Hwang DH, Sun H, Rodig SJ, Hornick JL, Sholl LM. Hwang DH, et al. Among authors: sholl lm. Histopathology. 2015 Jul;67(1):81-9. doi: 10.1111/his.12622. Epub 2015 Jan 20. Histopathology. 2015. PMID: 25407018

2

Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.

Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF. Sholl LM, et al. Am J Surg Pathol. 2007 Jun;31(6):947-52. doi: 10.1097/01.pas.0000249443.82971.bb. Am J Surg Pathol. 2007. PMID: 17527085

3

Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.

Sholl LM, John Iafrate A, Chou YP, Wu MT, Goan YG, Su L, Huang YT, Christiani DC, Chirieac LR. Sholl LM, et al. Mod Pathol. 2007 Oct;20(10):1028-35. doi: 10.1038/modpathol.3800946. Epub 2007 Aug 3. Mod Pathol. 2007. PMID: 17673923 Free article.

4

Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.

Sholl LM, Long KB, Hornick JL. Sholl LM, et al. Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):55-61. doi: 10.1097/PAI.0b013e3181b16b88. Appl Immunohistochem Mol Morphol. 2010. PMID: 19661786

5

Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.

Sholl LM, Yeap BY, Iafrate AJ, Holmes-Tisch AJ, Chou YP, Wu MT, Goan YG, Su L, Benedettini E, Yu J, Loda M, Jänne PA, Christiani DC, Chirieac LR. Sholl LM, et al. Cancer Res. 2009 Nov 1;69(21):8341-8. doi: 10.1158/0008-5472.CAN-09-2477. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826035 Free PMC article.

6

EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.

Sholl LM, Xiao Y, Joshi V, Yeap BY, Cioffredi LA, Jackman DM, Lee C, Jänne PA, Lindeman NI. Sholl LM, et al. Am J Clin Pathol. 2010 Jun;133(6):922-34. doi: 10.1309/AJCPST1CTHZS3PSZ. Am J Clin Pathol. 2010. PMID: 20472851 Free PMC article.

7

Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.

Benedettini E, Sholl LM, Peyton M, Reilly J, Ware C, Davis L, Vena N, Bailey D, Yeap BY, Fiorentino M, Ligon AH, Pan BS, Richon V, Minna JD, Gazdar AF, Draetta G, Bosari S, Chirieac LR, Lutterbach B, Loda M. Benedettini E, et al. Among authors: sholl lm. Am J Pathol. 2010 Jul;177(1):415-23. doi: 10.2353/ajpath.2010.090863. Epub 2010 May 20. Am J Pathol. 2010. PMID: 20489150 Free PMC article.

8

Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.

Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL. Sholl LM, et al. Am J Surg Pathol. 2010 Aug;34(8):1193-8. doi: 10.1097/PAS.0b013e3181e5e024. Am J Surg Pathol. 2010. PMID: 20631605 Free PMC article.

9

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab.

Nishino M, Cryer SK, Okajima Y, Sholl LM, Hatabu H, Rabin MS, Jackman DM, Johnson BE. Nishino M, et al. Among authors: sholl lm. Cancer Imaging. 2012 Jun 29;12(1):225-35. doi: 10.1102/1470-7330.2012.0027. Cancer Imaging. 2012. PMID: 22743083 Free PMC article.

10

Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM. Evans AG, et al. Among authors: sholl lm. Am J Surg Pathol. 2012 Aug;36(8):1222-7. doi: 10.1097/PAS.0b013e318258f03b. Am J Surg Pathol. 2012. PMID: 22790861 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page